A puzzling cosmic blast detected in both light and gravitational waves may hint at a previously unseen type of explosion, ...

Zoie Saunders, in an interview with VTDigger, said that it was "really of paramount importance that we stay the course" with lawmakers due to address a critical part of reform envisioned in Act 73 ...

In a lab rack that looks more like a high-end audio system than a server, clusters of human brain cells are quietly learning ...

Getting good at LeetCode Java isn’t just about solving problems; it’s about having a good plan. You need to know where to start, what tools to use, and how to keep going when things get tough. This ...

SAN FRANCISCO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...

SAN FRANCISCO, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...

From there, commercial products are expected to go on sale. Once the technology has matured, it will have a wide variety of satellite applications, including power-beaming arrays, space tugs, and data ...

Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...